Ono T - Search Results

1

Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.

Ono T, Sato S, Kimura N, Tanaka M, Shibuya A, Old LJ, Nakayama E. Ono T, et al. Int J Cancer. 2000 Dec 15;88(6):845-51. doi: 10.1002/1097-0215(20001215)88:6<845::aid-ijc1>3.0.co;2-n. Int J Cancer. 2000. PMID: 11093803

2

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.

Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E. Kurashige T, et al. Among authors: ono t. Cancer Res. 2001 Jun 15;61(12):4671-4. Cancer Res. 2001. PMID: 11406534

3

ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library.

Uenaka A, Hata H, Win S, Ono T, Wada H, Nakayama E. Uenaka A, et al. Among authors: ono t. Cancer Immun. 2001 Jul 13;1:8. Cancer Immun. 2001. PMID: 12747769

4

Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.

Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old LJ, Nakayama E. Ono T, et al. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3282-7. doi: 10.1073/pnas.041625098. Proc Natl Acad Sci U S A. 2001. PMID: 11248070 Free PMC article.

5

Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.

Manki A, Ono T, Uenaka A, Seino Y, Nakayama E. Manki A, et al. Among authors: ono t. Cancer Res. 1998 May 1;58(9):1960-4. Cancer Res. 1998. PMID: 9581839

6

Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.

Uenaka A, Ono T, Akisawa T, Wada H, Yasuda T, Nakayama E. Uenaka A, et al. Among authors: ono t. J Exp Med. 1994 Nov 1;180(5):1599-607. doi: 10.1084/jem.180.5.1599. J Exp Med. 1994. PMID: 7964448 Free PMC article.

7

Production of murine leukemia RLmale1 rejection antigen peptide pRL1a by proteolysis of natural precursor pRL1b.

Ono T, Uenaka A, Nakayama E. Ono T, et al. Jpn J Cancer Res. 1996 Nov;87(11):1165-70. doi: 10.1111/j.1349-7006.1996.tb03127.x. Jpn J Cancer Res. 1996. PMID: 9045946 Free PMC article.

8

Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1.

Yokoi T, Uenaka A, Ono T, Onizuka S, Inoue H, Nakayama E. Yokoi T, et al. Among authors: ono t. Int Immunol. 1997 Aug;9(8):1195-201. doi: 10.1093/intimm/9.8.1195. Int Immunol. 1997. PMID: 9263017

9

Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis.

Hiraki A, Ono T, Tanaka M, Kiura K, Ueoka H, Kawai H, Harada M, Nakayama E, Noguchi Y. Hiraki A, et al. Among authors: ono t. Anticancer Res. 2001 Jul-Aug;21(4A):2561-7. Anticancer Res. 2001. PMID: 11724322

10

Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.

Wada H, Ono T, Uenaka A, Monden M, Nakayama E. Wada H, et al. Among authors: ono t. Immunology. 1995 Apr;84(4):633-7. Immunology. 1995. PMID: 7790038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,625 results

Search Page

Filters